INTC
Intel Corporation
INTC has the edge over TBCH overall, supported by stronger fundamentals and stronger modeled upside.
TBCH
Turtle Beach Corporation
TBCH has lower modeled downside risk, despite its lower overall score.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
TBCH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Strong | |
| Weak |
TBCH's cash flow is currently strong, and its revenue is stable, but its profitability and balance sheet are under pressure.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
TBCH PE Valuation
TBCH has no meaningful PE right now: it lost money over the past year.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
TBCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TBCH, with profitability improving. However, they disagree widely on these estimates.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
TBCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.16 | — |
| Q3 2026 | -$0.06 | -107% |
| Q2 2026 | -$0.22 | -123% |
| Q1 2026 | $0.02 | -97% |
| Q4 2025 | $0.77 | -1.3% |
| Q3 2025 | $0.87 | +200% |
| Q2 2025 | $0.95 | +$1.03 |
| Q1 2025 | $0.74 | +$1.40 |
| Q4 2024 | $0.78 | +$1.85 |
TBCH has swung to a loss: it lost $0.06 per share over the past year, after a profit the year before.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC has the edge over TBCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over TBCH on profitability, with a higher operating margin.
TBCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $84.7M | +5.3% |
| Q2 2026 | $56.4M | -0.7% |
| Q1 2026 | $42.2M | -34% |
| Q4 2025 | $118.8M | -19% |
| Q3 2025 | $80.5M | -15% |
| Q2 2025 | $56.8M | -26% |
| Q1 2025 | $63.9M | +14% |
| Q4 2024 | $146.1M | +47% |
TBCH's revenue is recovering but still below its 2024 peak: $85M last quarter, up 5.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7% | +0.3 points |
| Q2 2026 | -5.4% | -4.8 points |
| Q1 2026 | -33% | -36 points |
| Q4 2025 | 18% | +1.6 points |
| Q3 2025 | 6.7% | -0.1 points |
| Q2 2025 | -0.6% | +4.8 points |
| Q1 2025 | 2.4% | +13 points |
| Q4 2024 | 16% | +7.6 points |
TBCH's operating margin was 7% last quarter, about level with the same quarter a year ago.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over TBCH on cash flow, with more consistent year-over-year improvement.
TBCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.3M | +$8.5M |
| Q2 2026 | $5.9M | +$9.4M |
| Q1 2026 | $29.1M | -28% |
| Q4 2025 | $13.1M | +2.3% |
| Q3 2025 | -$15.9M | +$8.7M |
| Q2 2025 | -$3.5M | +$10.4M |
| Q1 2025 | $40.3M | +52% |
| Q4 2024 | $12.8M | -32% |
TBCH usually generates cash, though not every quarter: the latest was −$7M, but it generated $41M over the past year.
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has 5.3B diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
TBCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.1% | -985K shares |
| 1 year | -11% | -2.2M shares |
| 3 years | +4.9% | +852K shares |
| 5 years | -0.8% | -138K shares |
| Available history | +16% | +2.5M shares |
TBCH has the edge over INTC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $25M |
| Q1 2026 | $2.2M |
| Q4 2025 | $2M |
| Q3 2025 | $10.3M |
| Q2 2025 | $5M |
| Q1 2025 | $1.8M |
| Q4 2024 | $2.4M |
TBCH spent $29M buying back its own shares over the past year, up 50% from the year before.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC has the edge over TBCH on leverage, with a lower net debt burden relative to earnings.
TBCH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.2x | High |
| Q2 2026 | 4.7x | High |
| Q1 2026 | 2.5x | Moderate |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 1.4x | Healthy |
TBCH's net debt is about 5.2 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
TBCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.8 | Neutral |
| Stochastic | 76.0 | Neutral |
TBCH's weekly RSI is 64 (neutral) and its Stochastic is 76 (neutral).
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
TBCH PE vs Technology Sector
| Metric | TBCH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
TBCH has no meaningful PE right now: it lost money over the past year.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 44% above its 200-week average.
TBCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.9 | 11% above |
| 20 week MA | $13.6 | 21% above |
| 50 week MA | $12.9 | 28% above |
| 100 week MA | $13.8 | 19% above |
| 200 week MA | $13.1 | 26% above |
TBCH has the edge over INTC on trend strength, trading above more of its moving averages.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over TBCH on returns for 2026, with the stronger performance.
TBCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.91 | $24.7 | +178% |
| 2021 | $24.7 | $24.5 | -1.1% |
| 2022 | $24.5 | $6.99 | -71% |
| 2023 | $6.99 | $11.0 | +57% |
| 2024 | $11.0 | $16.9 | +55% |
| 2025 | $16.9 | $14.2 | -16% |
| 2026 YTD | $14.2 | $16.5 | +17% |
TBCH's yearly returns have swung widely, from +178% in 2020 to −71% in 2022. It's up 17% so far in 2026.